[go: up one dir, main page]

AR230183A1 - Procedimiento para la preparacion de medicamentos con un alto grado de solubilidad y/o disolucion - Google Patents

Procedimiento para la preparacion de medicamentos con un alto grado de solubilidad y/o disolucion

Info

Publication number
AR230183A1
AR230183A1 AR291268A AR29126882A AR230183A1 AR 230183 A1 AR230183 A1 AR 230183A1 AR 291268 A AR291268 A AR 291268A AR 29126882 A AR29126882 A AR 29126882A AR 230183 A1 AR230183 A1 AR 230183A1
Authority
AR
Argentina
Prior art keywords
medicines
dissolution
solubility
procedure
preparation
Prior art date
Application number
AR291268A
Other languages
English (en)
Original Assignee
Elan Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp Ltd filed Critical Elan Corp Ltd
Application granted granted Critical
Publication of AR230183A1 publication Critical patent/AR230183A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AR291268A 1982-04-19 1982-11-11 Procedimiento para la preparacion de medicamentos con un alto grado de solubilidad y/o disolucion AR230183A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8206646A FR2525108B1 (fr) 1982-04-19 1982-04-19 Medicaments a haut degre de solubilite et procede pour leur obtention

Publications (1)

Publication Number Publication Date
AR230183A1 true AR230183A1 (es) 1984-03-01

Family

ID=9273120

Family Applications (1)

Application Number Title Priority Date Filing Date
AR291268A AR230183A1 (es) 1982-04-19 1982-11-11 Procedimiento para la preparacion de medicamentos con un alto grado de solubilidad y/o disolucion

Country Status (18)

Country Link
US (2) US4610875A (es)
JP (1) JPS58183615A (es)
AR (1) AR230183A1 (es)
AT (1) AT389813B (es)
AU (1) AU555579B2 (es)
BE (1) BE894942A (es)
CA (1) CA1225029A (es)
CH (1) CH655003A5 (es)
DE (1) DE3241097A1 (es)
ES (1) ES517444A0 (es)
FR (1) FR2525108B1 (es)
GB (1) GB2119784B (es)
IE (1) IE54084B1 (es)
IT (1) IT1153099B (es)
LU (1) LU84468A1 (es)
NL (1) NL8204461A (es)
PT (1) PT75867B (es)
SE (1) SE8206697L (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPS60139688A (ja) * 1983-12-28 1985-07-24 Tokyo Tanabe Co Ltd 無定形ジヒドロピリジン粉末製剤
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
WO1991007385A1 (en) * 1989-11-18 1991-05-30 Schering Agrochemicals Limited Preparation of propenoic acid derivatives
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
JPH0648937A (ja) * 1992-04-07 1994-02-22 Seitai Kagaku Kenkyusho:Kk 経口投与に適する薬剤およびその製造方法
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
FR2736550B1 (fr) * 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
US5686133A (en) * 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
WO1997034601A1 (fr) * 1996-03-18 1997-09-25 Eisai Co., Ltd. Compositions medicamenteuses a solubilite amelioree
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6517871B1 (en) * 1998-07-20 2003-02-11 Smithkline Beecham Corporation Bioenhanced formulations comprising eprosartan in oral solid dosage form
WO2000020033A1 (fr) 1998-10-05 2000-04-13 Eisai Co., Ltd. Comprimes se delitant immediatement dans la cavite buccale
JP5767429B2 (ja) * 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
BR0008058A (pt) * 1999-12-08 2002-03-26 Pharmacia Corp Forma de estado sólido de celecoxib tendo biodisposnibilidade melhorada
EP1738749A1 (en) 1999-12-23 2007-01-03 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
IL134701A0 (en) 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
EP1297836A4 (en) 2000-06-16 2007-06-13 Mitsubishi Pharma Corp COMPOSITIONS FOR REGULATING THE RANGE AND / OR SPEED OF PH RELEASE
JP4501054B2 (ja) * 2000-10-24 2010-07-14 味の素株式会社 ナテグリニド含有製剤
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
CZ20033456A3 (en) * 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
US20030170309A1 (en) * 2001-06-22 2003-09-11 Babcock Walter C. Pharmaceutical compositions containing polymer and drug assemblies
SI21223A (sl) * 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
US20050152932A1 (en) * 2003-06-12 2005-07-14 Valery Normand Non-crystalline perfume or flavor delivery system
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050048112A1 (en) 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
EP1827429A4 (en) * 2004-12-20 2009-08-05 Reddys Lab Ltd Dr PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS BENZIMIDAZOLE COMPOUNDS
RS52354B (en) * 2005-04-11 2012-12-31 Abbott Laboratories PHARMACEUTICAL MIXTURES WHICH HAVE ADVANCED DISSOLUTION PROFILES FOR Slightly Soluble Medicines
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
WO2007086039A1 (en) * 2006-01-27 2007-08-02 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin A method of producing porous microparticles
PT103743B (pt) * 2007-05-16 2013-01-15 Hovione Farmaciencia S A Processo para preparar derivados de 21-disódio fosfato de pregnanos.
CA2742356A1 (en) * 2008-11-04 2010-05-14 Cipla Limited Tiotropium bromide having a low degree of crystallinity
WO2012085236A1 (en) 2010-12-23 2012-06-28 Abbott Gmbh & Co. Kg Solid retard formulations based on solid dispersions
WO2012164575A2 (en) 2011-05-27 2012-12-06 Hetero Research Foundation Amorphous ritonavir co-precipitated

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
JPS5163925A (ja) * 1974-11-30 1976-06-02 Kyowa Hakko Kogyo Kk Muteikeikuroramufuenikooruno seizoho
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
JPS6024768B2 (ja) * 1979-06-16 1985-06-14 フロイント産業株式会社 活性化薬剤の製法
JPS55139319A (en) * 1979-04-13 1980-10-31 Furointo Sangyo Kk Activation of drug soluble in alkali and acid
JPS587609B2 (ja) * 1979-06-17 1983-02-10 フロイント産業株式会社 粉体薬剤のコ−テング法
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS5948810B2 (ja) * 1980-03-22 1984-11-29 山之内製薬株式会社 ニカルジピン持続性製剤用組成物
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
JPS5655370A (en) * 1979-10-13 1981-05-15 Kyorin Pharmaceut Co Ltd Amorphous nicomol
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
AT389813B (de) 1990-02-12
US4769236A (en) 1988-09-06
IE822610L (en) 1983-10-19
JPH0341444B2 (es) 1991-06-24
DE3241097A1 (de) 1983-10-20
FR2525108B1 (fr) 1989-05-12
IT8224368A0 (it) 1982-11-23
PT75867A (fr) 1982-12-01
AU9043182A (en) 1983-10-27
BE894942A (fr) 1983-05-09
GB2119784B (en) 1986-04-03
ES8505249A1 (es) 1985-05-16
US4610875A (en) 1986-09-09
SE8206697D0 (sv) 1982-11-24
ES517444A0 (es) 1985-05-16
PT75867B (fr) 1986-01-21
GB2119784A (en) 1983-11-23
SE8206697L (sv) 1983-10-20
ATA427282A (de) 1989-07-15
IE54084B1 (en) 1989-06-07
JPS58183615A (ja) 1983-10-26
DE3241097C2 (es) 1989-04-13
CH655003A5 (fr) 1986-03-27
LU84468A1 (fr) 1983-06-13
IT8224368A1 (it) 1984-05-23
AU555579B2 (en) 1986-10-02
FR2525108A1 (fr) 1983-10-21
CA1225029A (en) 1987-08-04
IT1153099B (it) 1987-01-14
NL8204461A (nl) 1983-11-16

Similar Documents

Publication Publication Date Title
AR230183A1 (es) Procedimiento para la preparacion de medicamentos con un alto grado de solubilidad y/o disolucion
BR1100036A (pt) Composto e composição farmacêutica
MX17752A (es) Formulaciones farmaceuticas y procedimiento para prepararlas
ES534114A0 (es) Procedimiento para la preparacion de nuevas n-alcoxi y n-alquil-sulfonilaminosulfonilureas
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
ES524892A0 (es) Un procedimiento para la preparacion de una tableta farmaceutica
ES555840A0 (es) Un procedimiento para la desproteccion de esteres y eteres alilicos
ES530593A0 (es) Un procedimiento para la preparacion de nuevos derivados de daunorrubicina y doxorrubicina
ES521864A0 (es) Un procedimiento para la preparacion de derivados de areno y hetero-arenocarboxamidas
MX7668A (es) Nuevos compuestos farmaceuticos y procedimiento para obtenerlos
IT1183060B (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
AR231279A1 (es) Un procedimiento para la preparacion de 2-2-benoil-3-mercaptopropionil amino-4-metiltio-butanoles quirales y acidos 2-2-bencil-3-metilmercaptopropionilamino-4-metil-tiobutiricos quirales
DK64183D0 (da) Farmaceutisk praeparat samt fremgangsmade til fremstilling deraf
DK272383D0 (da) Farmaceutisk blandingspraeparat
GB8308490D0 (en) Vials and syringes
NL190923C (nl) Farmaceutisch preparaat omvattende ibuprofen en caffeine.
NO822671L (no) Farmasoeytisk virksomme forbindelser og fremgangsmaate for deres fremstilling.
IT8348244A0 (it) Dispositivo chirurgico contenente sostamza farmaceutica ed emissione protratta
FI831687A0 (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
DK128485A (da) Farmaceutisk praeparat indeholdende tetracyclin- eller doxycyclinsalte og en fremgangsmaade til fremstilling af et saadant praeparat
DK314283D0 (da) Farmaceutiske praeparater
ES545234A0 (es) Un procedimiento para la preparacion de tiazol y tiazin-ben-cimidazoles
AR227962A1 (es) Procedimiento para preparar antibioticos ll-bo1208alpha y ll-bo1208beta
ES544287A0 (es) Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas farmaceuticamente aceptables
DK471783D0 (da) Farmaceutisk praeparat og fremgangsmade til fremstilling deraf